Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria.
Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria.
Alnylam Publishes Results From Phase IIa Study Of ALN-RSV01 In The Treatment Of Respiratory Syncytial Virus Infection In Lung Transplant Patients
Alnylam also hands over to Tekmira the intellectual property for the MC3 family of delivery lipids, but Alnylam can use the technology in its own products and sublicense it to partners. The agreement ends a dispute that began in March 2011 when Tekmira sued Alnylam for misuse of trade secrets...
Bull or Bear, Seeking Alpha is thereMarkets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. Continue with Google Continue with Apple or Create Free Account By creating an account using any of the options above, you agree to the Terms of ...
Shares of Alnylam Pharmaceuticals are sliding in morning trading despite the news that the company’s revenues grew by 83% in 2021 compared to the previous year.
Today's biotech news includes more layoffs and downsizing in the biotech world, Hims GLP-1 strategy backlash, and Zepbound's price cut.
Tesla Falls to Sixth Worst Stock in Russell 1000 It was the seventh best performer in the index during the first half of the year. TSLALBRAD Health & Wellness News May 24, 2017 9:29 AM EDT Biotech Movers: Inovio, Neurocrine, Alnylam Inovio Pharmaceuticals, Neurocrine Biosciences and Alnylam...
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years Apr. 15, 2025 at 7:15 p.m. ET on Benzinga.com Morgan Stanley Lowers Alnylam (ALNY) Price Target Amid Earnings Preview | ALNY Stock News Apr. 11, 2025 at 10:30 a.m. ET on GuruFocus...
1:24pBarron'sCapital One’s Discover Takeover Gets the Green Light. The Two Will Create the 6th-Largest U.S. Bank. 1:20pPicks‘Will we be okay?’ We are in our 50s with nearly $3M saved, no debt and $50K annual spending. But we avoid the stock market completely ...